Alkermes ALKS
NASDAQ ALKS
$45.39 -0.10 (-0.22%)
As of: Sep 9, 2026 · 12:35 PM EDT

Alkermes (ALKS) Gross Profit (2010 - 2026)

Alkermes' (ALKS) quarterly Gross Profit came in at $397.9 million in Q2 2026, up 16.62% year-over-year from $341.2 million in Q2 2025, and up 20.09% quarter-over-quarter from $331.3 million in Q1 2026.

Analysis

Alkermes (ALKS) Gross Profit (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Gross Profit for 17 consecutive years, with $397.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Gross Profit rose 16.62% year-over-year to $397.9 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 10.05% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 2.5% from the prior year.
  • Gross Profit was $397.9 million for Q2 2026 at Alkermes, up from $331.3 million in the prior quarter.
  • Over five years, Gross Profit peaked at $554.1 million in Q2 2023 and troughed at $201.7 million in Q3 2022.
  • A 5-year average of $312.5 million and a median of $317.2 million in 2023 frame the typical range for Gross Profit.
  • Across the five-year window, Gross Profit jumped 154.36% in 2023 and plunged 39.07% in 2024, its largest moves.
  • Over 5 years, Gross Profit stood at $250.8 million in 2022, then rose by 22.57% to $307.3 million in 2023, then grew by 19.69% to $367.9 million in 2024, then declined by 8.03% to $338.3 million in 2025, then gained by 17.6% to $397.9 million in 2026.
  • The last three Gross Profit figures came in at $397.9 million (Q2 2026), $331.3 million (Q1 2026), and $338.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.84 Bn 623.08 Bn 17.26 Bn
2 AbbVie 441.33 Bn 434.76 Bn 12.70 Bn
3 Merck 364.84 Bn 357.70 Bn 12.21 Bn
4 Novartis Ag 266.34 Bn 258.65 Bn 11.24 Bn
5 Pfizer 159.07 Bn 147.37 Bn 10.94 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn
7 Revolution Medicines 44.22 Bn 44.22 Bn -
8 Incyte 25.24 Bn 20.70 Bn 1.57 Bn
9 United Therapeutics 21.42 Bn 18.76 Bn 683.80 Mn
10 Alkermes 7.58 Bn 6.92 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 397.90 Mn
Mar 31, 2026 331.33 Mn
Dec 31, 2025 338.34 Mn
Sep 30, 2025 342.59 Mn
Jun 30, 2025 341.20 Mn
Mar 31, 2025 257.31 Mn
Dec 31, 2024 367.87 Mn
Sep 30, 2024 315.04 Mn
Jun 30, 2024 337.66 Mn
Mar 31, 2024 291.73 Mn
Dec 31, 2023 307.35 Mn
Sep 30, 2023 319.44 Mn
Jun 30, 2023 554.15 Mn
Mar 31, 2023 229.43 Mn
Dec 31, 2022 250.75 Mn
Sep 30, 2022 201.73 Mn
Jun 30, 2022 217.86 Mn
Mar 31, 2022 223.39 Mn
Dec 31, 2021 270.85 Mn
Sep 30, 2021 244.58 Mn